HKEX: 2190
Next Day Disclosure Return
Earlier from Zylox-tonbridge Medical Technology Co., Ltd. Class H
- Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%
- Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey
- Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year
- Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market